167 related articles for article (PubMed ID: 20621682)
21. Senescence suppressed proliferation of host hepatocytes is precondition for liver repopulation.
Chen J; Yang T; Song S; Liu Q; Sun Y; Zhao L; Fu Z; Wang MJ; Hu YP; Chen F
Biochem Biophys Res Commun; 2019 Aug; 516(2):591-598. PubMed ID: 31239154
[TBL] [Abstract][Full Text] [Related]
22. Hepatic progenitor cells of biliary origin with liver repopulation capacity.
Lu WY; Bird TG; Boulter L; Tsuchiya A; Cole AM; Hay T; Guest RV; Wojtacha D; Man TY; Mackinnon A; Ridgway RA; Kendall T; Williams MJ; Jamieson T; Raven A; Hay DC; Iredale JP; Clarke AR; Sansom OJ; Forbes SJ
Nat Cell Biol; 2015 Aug; 17(8):971-983. PubMed ID: 26192438
[TBL] [Abstract][Full Text] [Related]
23. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities.
Zhang RR; Zheng YW; Li B; Tsuchida T; Ueno Y; Nie YZ; Taniguchi H
Stem Cell Res Ther; 2015 Mar; 6(1):49. PubMed ID: 25889844
[TBL] [Abstract][Full Text] [Related]
24. Loss of p27(Kip1) enhances the transplantation efficiency of hepatocytes transferred into diseased livers.
Karnezis AN; Dorokhov M; Grompe M; Zhu L
J Clin Invest; 2001 Aug; 108(3):383-90. PubMed ID: 11489931
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
Kaldenbach M; Giebeler A; Tschaharganeh DF; Erschfeld S; Wasmuth HE; Dolle L; Floege J; Trautwein C; Streetz KL
Gut; 2012 Aug; 61(8):1209-18. PubMed ID: 22287599
[TBL] [Abstract][Full Text] [Related]
26. Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia.
Demers SI; Russo P; Lettre F; Tanguay RM
Hum Pathol; 2003 Dec; 34(12):1313-20. PubMed ID: 14691918
[TBL] [Abstract][Full Text] [Related]
27. Neonatal livers: a source for the isolation of good-performing hepatocytes for cell transplantation.
Tolosa L; Pareja-Ibars E; Donato MT; Cortés M; López S; Jiménez N; Mir J; Castell JV; Gómez-Lechón MJ
Cell Transplant; 2014; 23(10):1229-42. PubMed ID: 23803290
[TBL] [Abstract][Full Text] [Related]
28. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
Luijerink MC; van Beurden EA; Malingré HE; Jacobs SM; Grompe M; Klomp LW; Berger R; van den Berg IE
Kidney Int; 2004 Sep; 66(3):990-1000. PubMed ID: 15327392
[TBL] [Abstract][Full Text] [Related]
29. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
Kuo TK; Hung SP; Chuang CH; Chen CT; Shih YR; Fang SC; Yang VW; Lee OK
Gastroenterology; 2008 Jun; 134(7):2111-21, 2121.e1-3. PubMed ID: 18455168
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models.
Nicolas CT; Hickey RD; Allen KL; Du Z; Guthman RM; Kaiser RA; Amiot B; Bansal A; Pandey MK; Suksanpaisan L; DeGrado TR; Nyberg SL; Lillegard JB
Surgery; 2018 Sep; 164(3):473-481. PubMed ID: 29884476
[TBL] [Abstract][Full Text] [Related]
31. TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury.
Wang AW; Wangensteen KJ; Wang YJ; Zahm AM; Moss NG; Erez N; Kaestner KH
J Clin Invest; 2018 Jun; 128(6):2297-2309. PubMed ID: 29517978
[TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of long-term liver repopulation and the reconstitution of bile ductules after hepatocellular transplantation.
Zheng YW; Ohkohchi N; Taniguchi H
World J Gastroenterol; 2005 Oct; 11(39):6176-81. PubMed ID: 16273646
[TBL] [Abstract][Full Text] [Related]
33. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
Jiang J; Salido EC; Guha C; Wang X; Moitra R; Liu L; Roy-Chowdhury J; Roy-Chowdhury N
Transplantation; 2008 May; 85(9):1253-60. PubMed ID: 18475180
[TBL] [Abstract][Full Text] [Related]
34. Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates.
Dagher I; Nguyen TH; Groyer-Picard MT; Lainas P; Mainot S; Guettier C; Pariente D; Franco D; Weber A
Hepatology; 2009 Mar; 49(3):950-9. PubMed ID: 19152424
[TBL] [Abstract][Full Text] [Related]
35. Murine embryonic stem cell-derived hepatocytes correct metabolic liver disease after serial liver repopulation.
He ZY; Deng L; Li YF; Xiang D; Hu JK; Chen YX; Wang MJ; Chen F; Liu CC; Li WL; Zi XY; Wu X; Li GP; Wangensteen KJ; Hu YP; Wang X
Int J Biochem Cell Biol; 2012 Apr; 44(4):648-58. PubMed ID: 22249028
[TBL] [Abstract][Full Text] [Related]
36. Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes.
Boylan JM; Francois-Vaughan H; Gruppuso PA; Sanders JA
Transplantation; 2017 Oct; 101(10):2349-2359. PubMed ID: 28749819
[TBL] [Abstract][Full Text] [Related]
37. In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery.
Held PK; Olivares EC; Aguilar CP; Finegold M; Calos MP; Grompe M
Mol Ther; 2005 Mar; 11(3):399-408. PubMed ID: 15727936
[TBL] [Abstract][Full Text] [Related]
38. Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells.
Wang X; Al-Dhalimy M; Lagasse E; Finegold M; Grompe M
Am J Pathol; 2001 Feb; 158(2):571-9. PubMed ID: 11159194
[TBL] [Abstract][Full Text] [Related]
39. Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death.
Vogel A; van Den Berg IE; Al-Dhalimy M; Groopman J; Ou CN; Ryabinina O; Iordanov MS; Finegold M; Grompe M
Hepatology; 2004 Feb; 39(2):433-43. PubMed ID: 14767996
[TBL] [Abstract][Full Text] [Related]
40. Animal model for liver cell banking from non-heart beating donors after prolonged ischaemia time.
Porretti L; Gatti S; Gramignoli R; Colombo F; Lopa R; Cattaneo A; Scalamogna M; Colombo G; Rossi G; Bonino F; Rebulla P; Prati D
Dig Liver Dis; 2006 Dec; 38(12):905-11. PubMed ID: 16920045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
